Truica, C I; Byers, S; Gelmann, E P (2000) Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res 60:4709-13
|
Bowen, C; Voeller, H J; Kikly, K et al. (1999) Synthesis of procaspases-3 and -7 during apoptosis in prostate cancer cells. Cell Death Differ 6:394-401
|
Kimura, K; Bowen, C; Spiegel, S et al. (1999) Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis. Cancer Res 59:1606-14
|
Bowen, C; Spiegel, S; Gelmann, E P (1998) Radiation-induced apoptosis mediated by retinoblastoma protein. Cancer Res 58:3275-81
|
Cardillo, M; Berchem, G; Tarkington, M A et al. (1997) Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation. J Urol 158:212-6
|
Gumerlock, P H; Chi, S G; Shi, X B et al. (1997) p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network. J Natl Cancer Inst 89:66-71
|
Voeller, H J; Augustus, M; Madike, V et al. (1997) Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Res 57:4455-9
|
Gelmann, E P (1996) Androgen receptor mutations in prostate cancer. Cancer Treat Res 87:285-302
|
Voeller, H J; Sugars, L Y; Pretlow, T et al. (1994) p53 oncogene mutations in human prostate cancer specimens. J Urol 151:492-5
|
Carroll, A G; Voeller, H J; Sugars, L et al. (1993) p53 oncogene mutations in three human prostate cancer cell lines. Prostate 23:123-34
|